These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11245460)

  • 1. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
    Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL
    Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
    May C; James RI; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1444-51. PubMed ID: 8819532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI; May C; Vagt MD; Studebaker R; McIvor RS
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
    McIvor RS
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
    James R; May C; Diers M; Wagner J; McIvor R
    Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
    Gori JL; Podetz-Pedersen K; Swanson D; Karlen AD; Gunther R; Somia NV; McIvor RS
    J Pharmacol Exp Ther; 2007 Sep; 322(3):989-97. PubMed ID: 17586722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.
    Sweeney CL; Frandsen JL; Verfaillie CM; McIvor RS
    Cancer Res; 2003 Mar; 63(6):1304-10. PubMed ID: 12649191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.
    May C; Gunther R; McIvor RS
    Blood; 1995 Sep; 86(6):2439-48. PubMed ID: 7662992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a methotrexate resistant dihydrofolate reductase gene in transgenic mice.
    Isola LM; Gordon JW
    Dev Genet; 1989; 10(5):349-55. PubMed ID: 2480860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy].
    Gao HD; Lu P; Lu Y; Pang K; Xu HM; Wang SB; Chen JQ; Zhao SC
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):583-5. PubMed ID: 17236551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
    Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
    Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
    Havenga M; Valerio D; Hoogerbrugge P; Es H
    Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene.
    Capiaux GM; Budak-Alpdogan T; Alpdogan O; Bornmann W; Takebe N; Banerjee D; Maley F; Bertino JR
    Cancer Gene Ther; 2004 Dec; 11(12):767-73. PubMed ID: 15359285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
    Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K
    Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.